191 related articles for article (PubMed ID: 7507413)
41. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
Steinmetz KL; Klaunig JE
Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
[TBL] [Abstract][Full Text] [Related]
42. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
Kraupp-Grasl B; Huber W; Putz B; Gerbracht U; Schulte-Hermann R
Cancer Res; 1990 Jun; 50(12):3701-8. PubMed ID: 1971196
[TBL] [Abstract][Full Text] [Related]
43. Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.
Christensen JG; Romach EH; Healy LN; Gonzales AJ; Anderson SP; Malarkey DE; Corton JC; Fox TR; Cattley RC; Goldsworthy TL
Carcinogenesis; 1999 Aug; 20(8):1583-90. PubMed ID: 10426811
[TBL] [Abstract][Full Text] [Related]
44. Peroxisome proliferator-induced hepatocarcinogenesis: histochemical analysis of ciprofibrate-induced preneoplastic and neoplastic lesions for gamma-glutamyl transpeptidase activity.
Rao MS; Subbarao V; Reddy JK
J Natl Cancer Inst; 1986 Oct; 77(4):951-6. PubMed ID: 2876121
[TBL] [Abstract][Full Text] [Related]
45. Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.
Reddy JK; Rao MS
Br J Cancer; 1978 Oct; 38(4):537-43. PubMed ID: 728341
[TBL] [Abstract][Full Text] [Related]
46. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
[TBL] [Abstract][Full Text] [Related]
47. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883.
Eacho PI; Lanier TL; Brodhecker CA
Carcinogenesis; 1991 Sep; 12(9):1557-61. PubMed ID: 1893515
[TBL] [Abstract][Full Text] [Related]
48. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
[TBL] [Abstract][Full Text] [Related]
49. Absence of gamma-glutamyltranspeptidase activity in lung metastasis in rats with hepatocellular carcinomas induced by ciprofibrate, a peroxisome proliferator.
Milano M; Reddy JK; Prasad JD; Rao MS
Cancer Lett; 1987 Dec; 38(1-2):65-71. PubMed ID: 2891433
[TBL] [Abstract][Full Text] [Related]
50. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.
Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
J Environ Pathol Toxicol Oncol; 1992; 11(3):145-9. PubMed ID: 1625184
[TBL] [Abstract][Full Text] [Related]
51. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability.
Zerban H; Radig S; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1994 Nov; 15(11):2467-73. PubMed ID: 7955093
[TBL] [Abstract][Full Text] [Related]
52. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1219-26. PubMed ID: 8020159
[TBL] [Abstract][Full Text] [Related]
53. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR.
Elcombe CR; Elcombe BM; Foster JR; Chang SC; Ehresman DJ; Butenhoff JL
Toxicology; 2012 Mar; 293(1-3):16-29. PubMed ID: 22245121
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model.
Dewa Y; Nishimura J; Jin M; Kawai M; Saegusa Y; Kenmochi S; Shimamoto K; Harada T; Shibutani M; Mitsumori K
Arch Toxicol; 2011 Feb; 85(2):155-62. PubMed ID: 20502879
[TBL] [Abstract][Full Text] [Related]
55. Hepatocarcinogenesis by peroxisome proliferators.
Suga T
J Toxicol Sci; 2004 Feb; 29(1):1-12. PubMed ID: 15018150
[TBL] [Abstract][Full Text] [Related]
56. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
Greaves P; Irisarri E; Monro AM
J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179
[TBL] [Abstract][Full Text] [Related]
57. Hepatocarcinogenicity of dehydroepiandrosterone in the rat.
Rao MS; Subbarao V; Yeldandi AV; Reddy JK
Cancer Res; 1992 May; 52(10):2977-9. PubMed ID: 1316232
[TBL] [Abstract][Full Text] [Related]
58. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats.
Miller RT; Shah RS; Cattley RC; Popp JA
Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533
[TBL] [Abstract][Full Text] [Related]
59. Selective dieldrin promotion of hepatic focal lesions in mice.
Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
Carcinogenesis; 1996 Jun; 17(6):1243-50. PubMed ID: 8681438
[TBL] [Abstract][Full Text] [Related]
60. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643.
Bojes HK; Germolec DR; Simeonova P; Bruccoleri A; Schoonhoven R; Luster MI; Thurman RG
Carcinogenesis; 1997 Apr; 18(4):669-74. PubMed ID: 9111198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
